Towards elimination:: measles susceptibility in Australia and 17 European countries

被引:66
作者
Andrews, Nick
Tischer, Annedore [2 ]
Siedler, Annette [2 ]
Pebody, Richard G. [1 ]
Barbara, Christopher [3 ]
Cotter, Suzanne [4 ]
Duks, Arnis [5 ]
Gacheva, Nina [6 ]
Bohumir, Kriz [7 ]
Johansen, Kari [8 ]
Mossong, Joel [9 ]
de Ory, Fernando [10 ]
Prosenc, Katarina [11 ]
Slacikova, Margareta [12 ]
Theeten, Heidi [13 ]
Zarvou, Marios [14 ]
Pistol, Adriana [15 ]
Bartha, Kalman [16 ]
Cohen, Dani [17 ]
Backhouse, Jo [18 ]
Griskevicius, Algirdas [19 ]
Nardone, Anthony [1 ]
机构
[1] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England
[2] Robert Koch Inst, D-1000 Berlin, Germany
[3] St Lukes Hosp, Guardamangia, Malta
[4] Hlth Protect Surveillance Ctr, Dublin, Ireland
[5] Publ Hlth Agcy, Riga, Latvia
[6] Natl Ctr Infect & Parasit Dis, Sofia, Bulgaria
[7] Natl Inst Publ Hlth, Prague, Czech Republic
[8] Swedish Inst Infect Dis Control, Stockholm, Sweden
[9] Lab Natl Sante, Luxembourg, Luxembourg
[10] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Madrid, Spain
[11] Natl Inst Publ Hlth Slovenia, Ljubljana, Slovenia
[12] Publ Hlth Author Slovak Republ, Bratislava, Slovakia
[13] Univ Antwerp, B-2020 Antwerp, Belgium
[14] Nicosia Gen Hosp, Dept Immunol, Nicosia, Cyprus
[15] Natl Ctr Communicable Dis Prevent & Control, Bucharest, Romania
[16] Natl Ctr Epidemiol, Budapest, Hungary
[17] Tel Aviv Univ, Israel Ctr Dis Control, Tel Aviv, Israel
[18] Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia
[19] Lithuanian AIDS Ctr, Vilnius, Lithuania
关键词
D O I
10.2471/BLT.07.041129
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To evaluate age-specific measles susceptibility in Australia and 17 European countries. Methods As part of the European Sero-Epidemiology Network 2 (ESEN2), 18 countries collected large national serum banks between 1996 and 2004. These banks were tested for measles IgG and the results converted to a common unitage to enable valid intercountry comparisons. Historical vaccination and disease incidence data were also collected. Age-stratified population susceptibility levels were compared to WHO European Region targets for measles elimination of < 15% in those aged 2-4 years, < 10% in 5-9-year-olds and < 5% in older age groups. Findings Seven countries (Czech Republic, Hungary, Luxembourg, Spain, Slovakia, Slovenia and Sweden) met or came very close to the elimination targets. Four countries (Australia, Israel, Lithuania and Malta) had susceptibility levels above WHO targets in some older age groups indicating possible gaps in protection. Seven countries (Belgium, Bulgaria, Cyprus, England and Wales, Ireland, Latvia and Romania) were deemed to be at risk of epidemics as a result of high susceptibility in children and also, in some cases, adults. Conclusion Although all countries now implement a two-dose measles vaccination schedule, if the WHO European Region target of measles elimination by 2010 is to be achieved higher routine coverage as well as vaccination campaigns in some older age cohorts are needed in some countries. Without these improvements, continued measles transmission and outbreaks are expected in Europe.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 30 条
  • [1] The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella
    Andrews, N
    Pebody, RG
    Berbers, G
    Blondeau, C
    Crovari, P
    Davidkin, I
    Farrington, P
    Fievet-Groyne, F
    Gabutti, G
    Gerike, E
    Giordano, C
    Hesketh, L
    Marzec, T
    Morgan-Capner, P
    Osborne, K
    Pleisner, AM
    Raux, M
    Tischer, A
    Ruden, U
    Valle, M
    Miller, E
    [J]. EPIDEMIOLOGY AND INFECTION, 2000, 125 (01) : 127 - 141
  • [2] [Anonymous], STRAT PLAN MEASL CON
  • [3] The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication?
    Burgess, David C.
    Burgess, Margaret A.
    Leask, Julie
    [J]. VACCINE, 2006, 24 (18) : 3921 - 3928
  • [4] *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P175
  • [5] *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P304
  • [6] CRONIN M, 2000, MEASLES OUTBREAK REP, P9
  • [7] Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
    Davidkin, I
    Valle, M
    [J]. VACCINE, 1998, 16 (20) : 2052 - 2057
  • [8] Investigation of a rubella outbreak in Kyrgyzstan in 2001: Implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome
    Dayan, GH
    Zimmerman, L
    Shteinke, L
    Kasymbekova, K
    Uzicanin, Z
    Strebel, P
    Reef, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 187 : S235 - S240
  • [9] The seroepidemiology of measles in Western Europe
    de Melker, H
    Pebody, RG
    Edmunds, WJ
    Lévy-Bruhl, D
    Valle, M
    Rota, MC
    Salmaso, S
    van den Hof, S
    Berbers, G
    Saliou, P
    Conyn-van Spaendonck, M
    Crovari, P
    Davidkin, I
    Gabutti, G
    Hesketh, L
    Morgan-Capner, P
    Plesner, AM
    Raux, M
    Tischer, A
    Miller, E
    [J]. EPIDEMIOLOGY AND INFECTION, 2001, 126 (02) : 249 - 259
  • [10] Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region
    degli Atti, MLC
    Filia, A
    Massari, M
    Pizzuti, R
    Nicoletti, L
    D'Argenzio, A
    de Campora, E
    Marchi, A
    Lombardo, A
    Salmaso, S
    [J]. VACCINE, 2006, 24 (09) : 1332 - 1338